Interventional Cardiology Devices | Market Insights | Asia Pacific (Supplemental) | 2022
Despite the negative impact of the COVID-19 pandemic in the short term, the Asia-Pacific IC device market will grow modestly, driven by improving healthcare infrastructure, growing demand, and increasing availability of clinical data supporting the adoption of next-generation DES, BRS, and CTO-specific devices and advanced imaging techniques later in the forecast period. Increasing PCI volumes will all contribute to overall expansion through 2030. However, lack of reimbursement, cost constraints, and the impact of the COVID-19 pandemic will limit market growth to some extent.
This Medtech 360 Report provides high-level market metrics for IC devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across an 11-year period.
